Medicines and Healthcare products Regulatory Agency
1: Authorisation Number | UK MIA(IMP) 16993 |
---|---|
2: Name of authorisation holder | LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST |
3: Address(es) of manufacturing site(s) |
ROYAL LIVERPOOL UNIVERSITY HOSPITAL (CSSB), PHARMACY ASEPTIC UNIT, LEVEL 2- CLINICAL SUPPORT SERVICES BUILDING (CSSB), ROYAL LIVERPOOL UNIVERSITY HOSPITAL, MOUNT VERNON STREET, LIVERPOOL, L7 8YE, UNITED KINGDOM |
4: Legally registered address of authorisation holder | LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST, PHARMACY DEPARTMENT, ROYAL LIVERPOOL UNIVERSITY HOSPITAL, PRESCOT STREET, LIVERPOOL, L7 8XP, UNITED KINGDOM |
5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
6: Legal Basis of authorisation | |
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
8: Authorisation Date | 15/02/2024 |
9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
ROYAL LIVERPOOL UNIVERSITY HOSPITAL (CSSB), PHARMACY ASEPTIC UNIT, LEVEL 2- CLINICAL SUPPORT SERVICES BUILDING (CSSB), ROYAL LIVERPOOL UNIVERSITY HOSPITAL, MOUNT VERNON STREET, LIVERPOOL, L7 8YE, UNITED KINGDOM
Human Investigational Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Investigational Medicinal Products |
[ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
[ 1.1.1.1 ] Large volume liquids |
[ 1.1.1.4 ] Small volume liquids |
[ 1.1.1.6 ] Other aseptically prepared products Cytotoxics |
[ 1.1.3 ] Batch certification |
[ 1.3 ] Biological investigational medicinal products |
[ 1.3.1 ] Biological medicinal products |
[ 1.3.1.4 ] Gene therapy products |
[ 1.3.1.5 ] Biotechnology products |
[ 1.3.1.8 ] Other biological medicinal products Monoclonal antibodies |
[ 1.4 ] Other investigational medicinal products or manufacturing activitiy |
[ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
[ 1.4.2.1 ] Filtration |
[ 1.5 ] Packaging |
[ 1.5.2 ] Secondary packaging |